Collaborators in Clinical Trials
- Dept. of Psychiatry and Psychotherapy, LMU Munich (CBD-FEP, CBD-ESPRIT)
- Dept. of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen (CBD-ESPRIT)
- Dept. of Psychiatry and Psychotherapy, Charité Berlin (CBD-ESPRIT)
- Dept. of Psychiatry and Psychotherapy, University of Cologne (CBD-ESPRIT)
- Dept. of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf (CBD-ESPRIT)
Current and previous scientific collaborators
- Depts. of Pharmacology and Biological Chemistry, University of California, Irvine, CA, USA
- The Schizophrenia Center and Program in Molecular Psychiatry –
Johns Hopkins University, Baltimore, MD, USA - Institute of Pharmacology I, University of Cologne
- Institute of Radiochemistry and Experimental Molecular Imaging,
University of Cologne - Max-Planck-Institut for Brain Research, Frankfurt am Main
- Stanley Laboratory of Developmental Neurovirology –
Johns Hopkins University, Baltimore, MD, USA - Cambridge Center for Neuropsychiatric Research CCNR – University of Cambridge, UK
- Dept. of Pharmacology, University of Texas Health Science Center, San Antonio, TX, USA
Partners in Industry
- Endosane Pharmaceuticals GmbH, Berlin, Germany
- UBsane Diagnostics UG, Bruehl, Germany